Playing Defense In The House: PhRMA's Donut Hole Deal Garners Support From Democrats
This article was originally published in The Pink Sheet Daily
Seventy House Democrats support PhRMA's discount proposal in lieu of phasing out the Part D coverage gap with funds from new rebates collected on drugs for dual-eligibles.
You may also be interested in...
Waxman will keep pushing for Part D rebates to help fund closing the coverage gap, regardless of PhRMA's proposal for a different discount model. The good news for industry is that "dollars for donuts" remains the formula--and that even Waxman thinks industry will end up getting more than it gives.
PhRMA's commitment to contribute $80 billion toward health systems savings over the next 10 years looks like an important tactical win for the brand name industry entering the critical phase of the health reform debate
The House health care reform bill asks pharmaceutical manufacturers to pay their share of the cost of expanding health care coverage by paying higher rebates on more drugs